Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹1,291 Cr
up ₹33.2 Cr vs Feb 2022
- Stocks held
- 24
- unchanged
- Top 10 weight
- 68.1%
- of the portfolio in its ten largest
- Cash & debt
- −<0.1%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 10, trimmed 8
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In March 2022 it disclosed 24 stocks worth ₹1,291 Cr, up ₹33.2 Cr from Feb 2022. Its largest positions were Sun Pharmaceutical Industries Limited (14.4%), Cipla Limited (9.6%), Max Healthcare Institute Limited (7.1%); the ten largest together made up 68.1% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 54.7% of its equity. Cash and debt stood at −<0.1%. Compared with Feb 2022 the fund entered 0 new stocks and exited 0.
Against 229 other Sectoral / Thematic funds
Concentration
93%
Top-10 weight is higher than 93% of peers
Breadth
7%
Holds more stocks than 7% of peers
Cash
1%
Holds more cash than 1% of peers
What these mean: concentration · cash
Holdings in March 2022
Download CSVEvery line the fund disclosed, with the change against Feb 2022. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Sun Pharmaceutical Industries Limited | 14.40% | up 0.77 pts | ₹186 Cr | up ₹14.4 Cr | Added |
| Cipla Limited | 9.59% | up 0.65 pts | ₹124 Cr | up ₹11.3 Cr | Added |
| Max Healthcare Institute Limited | 7.13% | down 0.81 pts | ₹92.1 Cr | down ₹7.8 Cr | Trimmed |
| Apollo Hospitals Enterprise Limited | 6.89% | down 0.68 pts | ₹89 Cr | down ₹6.3 Cr | Trimmed |
| IPCA Laboratories Limited | 6.52% | up 0.36 pts | ₹84.1 Cr | up ₹6.7 Cr | Added |
| Dr. Reddy's Laboratories Limited | 5.57% | up 0.16 pts | ₹71.9 Cr | up ₹3.9 Cr | Added |
| Lupin Limited | 4.97% | down 0.12 pts | ₹64.2 Cr | up ₹10 L | Held |
| Procter & Gamble Health Limited | 4.92% | down 0.84 pts | ₹63.5 Cr | down ₹9 Cr | Trimmed |
| Alkem Laboratories Limited | 4.71% | up 0.33 pts | ₹60.8 Cr | up ₹5.8 Cr | Added |
| Vijaya Diagnostic Centre Limited | 3.46% | up 0.04 pts | ₹44.7 Cr | up ₹1.7 Cr | Added |
| Intuitive Surgical Inc | 3.38% | up 0.11 pts | ₹43.6 Cr | up ₹2.6 Cr | Added |
| Indoco Remedies Limited | 3.28% | down 0.22 pts | ₹42.4 Cr | down ₹1.7 Cr | Trimmed |
| Globus Medical Inc | 2.94% | up 0.14 pts | ₹37.9 Cr | up ₹2.8 Cr | Added |
| Abiomed Inc | 2.67% | up 0.20 pts | ₹34.5 Cr | up ₹3.5 Cr | Added |
| ICICI Lombard General Insurance Company Limited | 2.48% | up 0.06 pts | ₹32.1 Cr | up ₹1.6 Cr | Added |
| Abbott Laboratories | 2.23% | down 0.03 pts | ₹28.8 Cr | up ₹32 L | Added |
| Syngene International Limited | 2.15% | up 0.15 pts | ₹27.8 Cr | up ₹2.6 Cr | Added |
| Narayana Hrudayalaya Limited | 2.07% | down 0.13 pts | ₹26.8 Cr | down ₹94 L | Trimmed |
| Global X Funds - Global X Genomics & Biotechnology ETF Fund units | 1.78% | down 0.06 pts | ₹22.9 Cr | down ₹19 L | Trimmed |
| Illumina Inc | 1.73% | up 0.10 pts | ₹22.4 Cr | up ₹1.8 Cr | Added |
| Alembic Pharmaceuticals Limited | 1.56% | down 0.01 pts | ₹20.1 Cr | up ₹44 L | Added |
| Aarti Drugs Limited | 1.55% | down 0.14 pts | ₹20.1 Cr | down ₹1.2 Cr | Trimmed |
| MedPlus Health Services Limited | 1.51% | down 0.06 pts | ₹19.5 Cr | down ₹29 L | Trimmed |
| Unichem Laboratories Limited | 1.32% | up <0.01 pts | ₹17.1 Cr | up ₹47 L | Added |
| Kovai Medical Center and Hospital Limited | 1.22% | up 0.01 pts | ₹15.8 Cr | up ₹48 L | Added |
| Cash, TREPS & receivables | −0.02% | up 0.02 pts | −₹26 L | up ₹24 L | Added |
What changed, Feb 2022 to Mar 2022
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Sun Pharmaceutical Industries Limitedup ₹14.4 Cr (+0.77% pts)
- Cipla Limitedup ₹11.3 Cr (+0.65% pts)
- IPCA Laboratories Limitedup ₹6.7 Cr (+0.36% pts)
- Alkem Laboratories Limitedup ₹5.8 Cr (+0.33% pts)
- Dr. Reddy's Laboratories Limited ₹3.9 Cr (+0.16% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Feb 2022, the weight rose most in Pharmaceuticals & Biotechnology (+1.1 pts) and Healthcare Equipment & Supplies (+0.3 pts), and fell most in Healthcare Services (−1.1 pts) and Pharmaceuticals (−0.3 pts).
- Pharmaceuticals & Biotechnology53.6% → 54.7%+1.1 pts
- Healthcare Equipment & Supplies6.2% → 6.4%+0.3 pts
- Healthcare Services29.0% → 27.8%−1.1 pts
- Pharmaceuticals7.2% → 7.0%−0.3 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Mar 2019 | Mar 2021 | Sep 2021 | Dec 2021 | Feb 2022 | Mar 2022 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 70.6% | 64.2% | 59.2% | 52.7% | 53.6% | 54.7% |
| Healthcare Services | 15.1% | 22.2% | 25.7% | 29.8% | 29.0% | 27.8% |
| Pharmaceuticals | 11.9% | 7.1% | 6.6% | 7.3% | 7.2% | 7.0% |
| Healthcare Equipment & Supplies | — | 3.2% | 5.9% | 6.3% | 6.2% | 6.4% |
| Insurance | 2.3% | 3.3% | 2.6% | 2.4% | 2.5% | 2.5% |
| Retailing | — | — | — | 1.4% | 1.6% | 1.5% |
Allocation in Mar 2022change vs Feb 2022
- Pharmaceuticals & Biotechnology (9)54.7%▲ 1.1 pts
- Healthcare Services (8)27.8%▼ 1.1 pts
- Pharmaceuticals (3)7.0%▼ 0.3 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Mar 2022
−<0.1%
unchanged vs Feb 2022
- Cash alone
- −<0.1%
- cash and net receivables
- A year earlier
- 5.3%
- Mar 2021 · now ▼ 5.4 pts
- Last 12 months
- −0.3% – 6.4%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.